Evaluation of cell-free DNA as a biomarker for pancreatic malignancies

International Journal of Biological Markers

Volumn 30, Issue 1, 2015, Pages e136-e141

  Sikora, Katarzyna ^a   Bedin, Chiara ^b   Vicentini, Caterina ^a   Malpeli, Giorgio ^a   D’Angelo, Edoardo ^a   Sperandio, Nicola ^a   Lawlor, Rita T ^a   Bassi, Claudio ^a   Tortora, Giampaolo ^c   Nitti, Donato ^b   Agostini, Marco ^b,d,e   Scarpa, Aldo ^a   Fassan, Matteo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e Pediatric Research Institute   (Italy)

Author keywords

Alu sequences; Biomarkers; Cell free DNA; Pancreatic tumors

Indexed keywords

BIOLOGICAL MARKER; DNA; TUMOR MARKER;

ADULT; ARTICLE; CELL FREE DNA; CELL FREE SYSTEM; CHRONIC PANCREATITIS; DNA EXTRACTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREATIC NEUROENDOCRINE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; AGED; BLOOD; CARCINOMA, PANCREATIC DUCTAL; CASE CONTROL STUDY; MIDDLE AGED; PANCREATIC NEOPLASMS; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; ROC CURVE;

EID: 84929049678     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/jbm.5000088     Document Type: Article

References (20)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
2. Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg. 2004;198(5):722-731.
3. Goggins M. Molecular markers of early pancreatic cancer. J Clin Oncol. 2005;23(20):4524-4531.
4. Marchese R, Muleti A, Pasqualetti P, et al. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA. Pancreas. 2006;32(2):171-177.
5. Corbo V, Tortora G, Scarpa A. Molecular pathology of pancreatic cancer: from bench-to-bedside translation. Curr Drug Targets. 2012;13(6):744-752.
6. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426-437.
7. Umetani N, Giuliano AE, Hiramatsu SH, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 2006;24(26):4270-4276.
8. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas. 1998;17(1):89-97.
9. Agostini M, Enzo MV, Bedin C, et al. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients. Cancer Biomark. 2012;11(2-3): 89-98.
10. Agostini M, Pucciarelli S, Enzo MV, et al. Circulating cellfree DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Ann Surg Oncol. 2011;18(9):2461-2468.
11. Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evi dence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61(4):1659-1665.
12. Wang BG, Huang HY, Chen YC, et al. Increased plasma DNA integrity in cancer patients. Cancer Res. 2003;63(14): 3966-3968.
13. Schneider T, Osl F, Friess T, Stockinger H, Scheuer WV. Quantification of human Alu sequences by real-time PCR—an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants. Clin Exp Metastasis. 2002;19(7):571-582.
14. Umetani N, Hiramatsu S, Hoon DS. Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation. Ann N Y Acad Sci. 2006;1075(1):299-307.
15. Umetani N, Kim J, Hiramatsu S, et al. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem. 2006;52(6):1062-1069.
16. Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res. 2007;635(2-3):105-117.
17. Anker P, Lyautey J, Lederrey C, Stroun M. Circulating nucleic acids in plasma or serum. Clin Chim Acta. 2001;313(1-2): 143-146.
18. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta. 2001;313(1-2):139-142.
19. Kamat AA, Sood AK, Dang D, Gershenson DM, Simpson JL, Bischoff FZ. Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR. Ann N Y Acad Sci. 2006;1075(1):230-234.
20. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology. 2007;39(2):197-207.